Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent recurrence of breast cancer following surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas. Show More...
-
Website http://greenwichlifesciences.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 10.81 USD
-
Last Updated 14-07-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 2020-12 TTM Earnings Per Share USD -0.14 -0.29 -0.2 -0.17 Dividends USD Payout Ratio % * Shares Mil 12.0 12.0 9.0 13.0 Book Value Per Share * USD 0.37 2.31 Free Cash Flow Per Share * USD -0.02 Return on Assets % -12.98 -7.28 Financial Leverage (Average) 1.04 1.02 Return on Equity % -14.18 -7.45 Return on Invested Capital % -14.18 -7.46 Interest Coverage Current Ratio 0.12 0.010 27.41 45.17 Quick Ratio 0.12 0.010 27.41 45.17 Debt/Equity